BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18322684)

  • 1. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.
    Boullart AC; Aarntzen EH; Verdijk P; Jacobs JF; Schuurhuis DH; Benitez-Ribas D; Schreibelt G; van de Rakt MW; Scharenborg NM; de Boer A; Kramer M; Figdor CG; Punt CJ; Adema GJ; de Vries IJ
    Cancer Immunol Immunother; 2008 Nov; 57(11):1589-97. PubMed ID: 18322684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of toll-like receptor agonists and prostaglandin E(2) in the FastDC model: rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production.
    Dauer M; Lam V; Arnold H; Junkmann J; Kiefl R; Bauer C; Schnurr M; Endres S; Eigler A
    J Immunol Methods; 2008 Sep; 337(2):97-105. PubMed ID: 18657542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell-independent, TLR-induced IL-12p70 production in primary human monocytes.
    Bekeredjian-Ding I; Roth SI; Gilles S; Giese T; Ablasser A; Hornung V; Endres S; Hartmann G
    J Immunol; 2006 Jun; 176(12):7438-46. PubMed ID: 16751389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
    Krumbiegel D; Zepp F; Meyer CU
    Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
    Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
    J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol.
    Fevžer T; Poženel P; Zajc K; Tešić N; Švajger U
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of CD40 ligation and interferon-gamma on functional properties of human monocyte-derived dendritic cells activated with polyinosinic-polycytidylic acid.
    Dragicević A; Dzopalić T; Vasilijić S; Vucević D; Bozić B; Majstorović I; Balint B; Colić M
    Vojnosanit Pregl; 2011 Apr; 68(4):301-8. PubMed ID: 21627015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src kinases are required for a balanced production of IL-12/IL-23 in human dendritic cells activated by Toll-like receptor agonists.
    Kuka M; Baronio R; Valentini S; Monaci E; Muzzi A; Aprea S; De Gregorio E; D'Oro U
    PLoS One; 2010 Jul; 5(7):e11491. PubMed ID: 20634889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.
    Lövgren T; Sarhan D; Truxová I; Choudhary B; Maas R; Melief J; Nyström M; Edbäck U; Vermeij R; Scurti G; Nishimura M; Masucci G; Karlsson-Parra A; Lundqvist A; Adamson L; Kiessling R
    Cancer Immunol Immunother; 2017 Oct; 66(10):1333-1344. PubMed ID: 28601925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075.
    Spranger S; Javorovic M; Bürdek M; Wilde S; Mosetter B; Tippmer S; Bigalke I; Geiger C; Schendel DJ; Frankenberger B
    J Immunol; 2010 Jul; 185(1):738-47. PubMed ID: 20511554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
    Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
    J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma.
    Brencicova E; Jagger AL; Evans HG; Georgouli M; Laios A; Attard Montalto S; Mehra G; Spencer J; Ahmed AA; Raju-Kankipati S; Taams LS; Diebold SS
    PLoS One; 2017; 12(4):e0175712. PubMed ID: 28410380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation.
    van den Ancker W; van Luijn MM; Ruben JM; Westers TM; Bontkes HJ; Ossenkoppele GJ; de Gruijl TD; van de Loosdrecht AA
    Cancer Immunol Immunother; 2011 Jan; 60(1):37-47. PubMed ID: 20859626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.
    Zobywalski A; Javorovic M; Frankenberger B; Pohla H; Kremmer E; Bigalke I; Schendel DJ
    J Transl Med; 2007 Apr; 5():18. PubMed ID: 17430585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
    Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
    J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E
    Yi DH; Stetter N; Jakobsen K; Jonsson R; Appel S
    Cancer Immunol Immunother; 2018 Oct; 67(10):1611-1620. PubMed ID: 30069688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells.
    Nouri-Shirazi M; Tamjidi S; Nourishirazi E; Guinet E
    Immunol Lett; 2018 Jan; 193():58-66. PubMed ID: 29103998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.
    Jongmans W; Tiemessen DM; van Vlodrop IJ; Mulders PF; Oosterwijk E
    J Immunother; 2005; 28(5):480-7. PubMed ID: 16113604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.